IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 18 December 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01203-06v1
75/3/1335    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wickstrum, J. R.
Right arrow Articles by Parmely, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wickstrum, J. R.
Right arrow Articles by Parmely, M. J.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01203-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Co-activating Signals for the Hepatic Lymphocyte Interferon-{gamma} Response to Francisella tularensis

Jason R. Wickstrum, Kee-Jong Hong, Sirosh Bokhari, Natalie Reed, Nicholas McWilliams, Rebecca T. Horvat, and Michael J. Parmely*

Department of Microbiology, Molecular Genetics, and Immunology, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160

* To whom correspondence should be addressed. Email: mparmely{at}kumc.edu.


   Abstract

The facultative intracellular bacterium Francisella tularensis is capable of causing systemic infections in various hosts, including mice and humans. The liver is a major secondary site of F. tularensis infection, but hepatic immune responses to the pathogen remain poorly defined. Immune protection against the pathogen is thought to depend on the cytokine interferon-gamma (IFN-{gamma}), but the cellular basis for this response has not been characterized. Here we report that natural killer cells from the livers of naïve uninfected mice produced IFN-{gamma} when challenged with live bacteria in vitro and that the responses were greatly increased by co-activation of the cells with either recombinant interleukin-12 or interleukin-18. Moreover, the two cytokines had strong synergistic effects on IFN-{gamma} induction. Neutralizing antibodies to either IL-12 or IL-18 inhibited IFN-{gamma} production in vitro, and mice deficient in the p35 subunit of IL-12 failed to show IFN-{gamma} responses to bacterial challenge either in vitro or in vivo. Clinical isolates of highly virulent type A F. tularensis subsp. tularensis organisms were comparable to the attenuated live vaccine strain of F. tularensis subsp. holartica in their ability to induce IL-12 and IFN-{gamma} expression. These findings demonstrate that cells capable of mounting IFN-{gamma} responses to F. tularensis are resident within the livers of uninfected mice and depend upon co-activation by IL-12 and IL-18 for optimum responses.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.